| Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States (NCT00266513) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-14 |
| STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency (NCT00263237) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-02 |
| Hospital Based Incidence of Group A Streptococcal Disease in Fiji (NCT00264771) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-01 |
| Mercury Levels in Premature and LBW Infants Receiving Thimerosal-containing Vaccines (NCT00138333) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-01 |
| GAS Epi Study to Measure Age-Related Antibody Titers to J8 Vaccine (NCT00264784) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-01 |
| Immune Response to Varicella Vaccination in Children With Atopic Dermatitis (NCT00406081) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-01 |
| Pentavalent DTaP-Hep B-IPV (NCT00133445) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-01 |
| Omalizumab to Treat Hyper-IgE (Job's) Syndrome (NCT00260702) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-24 |
| Immune Response to Mycobacterium Tuberculosis Infection (NCT00257907) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-18 |
| The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease (NCT00250198) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-03 |
| Relationship Between HIV and Malaria in Ugandan Children (NCT00356824) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-01 |
| Chart Review of Antivirals for Influenza in Infants (NCT00311701) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-01 |
| Immunogenicity and Safety of Different Doses of Fluzone® Influenza (NCT00253734) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-01 |
| Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities (NCT00311649) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-01 |
| Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults (NCT00124007) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-01 |
| Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults (NCT00099684) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-01 |
| T-cell Response-Flu Risk in Older Adults (NCT00138398) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-25 |
| RSV Disease in the Elderly (NCT00246480) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-03 |
| Immune Responses to Two Dose Varivax +/- MMR-II (NCT00258726) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-01 |
| Monoclonal Antibody for Treatment of Inhalation Anthrax (NCT00138411) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-01 |
| Inactivated Influenza A/H5N1 Vaccine in the Elderly (NCT00230750) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-01 |
| H5 Booster After a Two Dose Schedule (NCT00240968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-01 |
| Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine (NCT00240903) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-01 |
| Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine (NCT00311727) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-01 |
| Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women (NCT00102986) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-01 |
| ACAM 3000 MVA at Harvard Medical School (NCT00133575) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-01 |
| Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant (NCT00135694) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-01 |
| Evaluation of Patients With Immune Function Abnormalities (NCT00128973) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-19 |
| Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People (NCT00110812) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult Participants (NCT00125970) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| Zinc and Pneumonia Protocol (NCT00133432) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes (NCT00129259) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| Comparison of Delivery Routes of Flu Vaccine in Adults (NCT00170547) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China (NCT00346762) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist (NCT00231907) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) (NCT00230035) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| Analysis of Lyme Disease Lesions (NCT00132327) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-08-17 |
| Changes in HIV Viral Load in Patients Undergoing Treatment for Filariasis (NCT00344279) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-08-08 |
| Examination of Protective Factors Against Severe Malaria (NCT00342043) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-08-02 |
| Herpevac Neonatal Substudy (NCT00138320) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-08-01 |
| Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment (NCT00138385) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-08-01 |
| Severe Malaria and Anti-malarial Drug Resistance in Cambodia (NCT00341003) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-22 |
| Collection of Convalescent SARS Plasma by Apheresis (NCT00342524) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-06 |
| Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis (NCT00407979) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-01 |
| H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults (NCT00310206) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-01 |
| Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African Adults (NCT00270764) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-01 |
| Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults (NCT00118924) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-01 |
| Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised (NCT00238459) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-01 |
| Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth (NCT00102960) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-01 |
| A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression (NCT00091871) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-06-08 |
| SCOT Scleroderma Treatment Alternative Registry (STAR Registry) (NCT00860548) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-06-01 |
| Scleroderma: Cyclophosphamide or Transplantation (NCT00114530) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-06-01 |
| Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients (NCT00105235) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-06-01 |
| Young Adult Influenza Vaccine Immunogenicity Substudy (NCT00170508) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-06-01 |
| Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus (NCT00407069) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-06-01 |
| Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A) (NCT00110279) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-06-01 |
| Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection (NCT00111397) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-13 |
| CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi (NCT00125489) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China (NCT00100594) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| AMA1-C1/Alhydrogel + CpG 7909 for Malaria (NCT00344539) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis (NCT00145249) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density (NCT00102908) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis (NCT00094172) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy (NCT00109603) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| "Prime-Boost" Vaccine Schedule for Prevention of HIV Infection (NCT00109629) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-26 |
| Elderly Influenza Vaccine Immunogenicity Substudy (NCT00170482) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-25 |
| Vaccine Treatment for HIV-Infection (NCT00108654) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-13 |
| Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs (NCT00099671) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes (NCT00076232) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Eldery High Dose TIV 2005 (NCT00115531) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Experimental Vaccine for Malaria (NCT00114010) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (NCT00119405) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Tuberculosis Immunity in Children (NCT00170638) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults (NCT00119379) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS (NCT00106795) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-22 |
| Vaccine to Prevent West Nile Virus Disease (NCT00106769) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-22 |
| Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark) (NCT00340574) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-08 |
| PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria (NCT00295581) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-07 |
| Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults (NCT00133471) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment (NCT00105417) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial (NCT00100386) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Effects of Anti-HIV Therapy on Nervous System Function (NCT00432003) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| A/H5N1in Adult - Aventis (NCT00115986) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection (NCT00239733) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Urban Environmental Factors and Childhood Asthma (NCT00114881) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-02-02 |
| Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults (NCT00094718) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-02-01 |
| Preventing Sexual Transmission of HIV With Anti-HIV Drugs (NCT00074581) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-02-01 |
| A Study of Anal Cancer Development in HIV Infected People (NCT00107679) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-02-01 |
| Strategies for Delivering Anti-HIV Therapy in South Africa (NCT00080522) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-02-01 |
| Clinical and Immunological Evaluation of Children With Allergies (NCT00102570) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-26 |
| HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers (NCT00102089) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-18 |
| Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients (NCT00101374) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-05 |
| Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research (NCT00341042) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-04 |
| Multi-Drug Resistant Tuberculosis in Korea (NCT00341601) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-03 |
| Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis (NCT00104299) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |
| Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients (NCT00240994) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |
| Collection of Blood Samples From HIV Infected People (NCT00096772) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |
| BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women (NCT00074425) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |
| Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults (NCT00094705) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |
| Computer-Generated Vs. Standard Informed Consent for HIV Research Studies (NCT00104559) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |